Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma

NCT03200847 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Melanoma
Stage III Melanoma
Advanced Melanoma

Interventions

DRUG: Pembrolizumab with All-Trans Retinoic Acid

Sponsor

University of Colorado, Denver

Collaborators

[object Object]